Design and rationale of the MODULAR ATP global clinical trial: A novel intercommunicative leadless pacing system and the subcutaneous implantable cardioverter-defibrillator

Figures

• 

  Figure 1. Modular cardiac rhythm management (mCRM) therapy system. A: The mCRM therapy system: leadless pacemaker and subcutaneous implantable cardioverter-defibrillator pulse generators. B: Illustration of the implanted mCRM therapy system.

• 

  Figure 2. Study overview. mCRM = modular cardiac rhythm management; S-ICD = subcutaneous implantable cardioverter-defibrillator.

• 

  Figure 3. Endpoint analysis. Temporal and conditional map of endpoints, designed to minimize type I errors. S-ICD = subcutaneous implantable cardioverter-defibrillator; PG = pulse generator.